Company: TEAM
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001650372-25-000068
Chunk: 242

Company: Atlassian Corp
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 8
Chunk 242
---
1,002,578$739,524$263,054 $1,002,578The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2025 (in thousands):Notional Amounts of Derivative InstrumentsNotional Amount by Term to MaturityClassification by Notional AmountUnder 12 monthsOver 12 monthsTotalCash Flow HedgeNon HedgeTotalForward contracts$1,064,280 $79,858$1,144,138$765,613$378,525 $1,144,138

14

The fair values of the Company’s derivative instruments were as follows (in thousands):Balance Sheet LocationSeptember 30, 2025June 30, 2025Derivative assetsDerivatives designated as hedging instruments:Foreign exchange forward contractsPrepaid expenses and other current assets$17,080 $16,210 Foreign exchange forward contractsOther non-current assets288 3,715 Derivatives not designated as hedging instruments:Foreign exchange forward contractsPrepaid expenses and other current assets1,086 3,309 Total derivative assets$18,454 $23,234 Derivative liabilitiesDerivatives designated as hedging instruments:Foreign exchange forward contractsAccrued expenses and other current liabilities$4,794 $2,409 Foreign exchange forward contractsOther non-current liabilities432 — Derivatives not designated as hedging instruments:Foreign exchange forward contractsAccrued expenses and other current liabilities163 36 Total derivative liabilities$5,389 $2,445 The pre-tax effects of derivatives designated as cash flow hedging instruments on the condensed consolidated financial statements were as follows (in thousands):Three Months Ended September 30,20252024Beginning balance of accumulated gains in accumulated other comprehensive income (loss)$24,679 $41,424 Gross unrealized gains (losses) recognized in other comprehensive income (loss)(6,709)18,015 Net losses (gains) reclassified from cash flow hedge in accumulated other comprehensive income (loss) into profit or loss:Recognized in cost of revenues180 (43)Recognized in research and development1,083 (440)Recognized in marketing and sales47 57 Recognized in general and administrative263 72 Recognized in interest expense(5,552)(7,155)Ending balance of accumulated gains in accumulated other comprehensive income (loss)$13,991